Citalopram NDC 59651-964

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-964Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0964Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-964-30	59651096430	30 CAPSULE in 1 BOTTLE (59651-964-30)Marketed from Mar 13, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Citalopram
Generic name (nonproprietary): citalopram
Active ingredients: Citalopram hydrobromide — 30 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219985
Marketing start: Mar 13, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 59651-964_80af8ae8-c106-4895-bab3-0579b41f1e75SPL ID 80af8ae8-c106-4895-bab3-0579b41f1e75SPL set ID 80af8ae8-c106-4895-bab3-0579b41f1e75RxCUI 2591786UNII I1E9D14F36UPC 0359651964309
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651096430 followed by a unit qualifier and the quantity

Package 59651-0964-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 18, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Citalopram capsules are indicated for the treatment of Major Depressive Disorder (MDD) in adults [see Clinical Studies (14) ] . Citalopram capsules is a selective serotonin reuptake inhibitor (SSRI) indicated for treatment of Major Depressive Disorder (MDD) in adults ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)